Search bioRxiv⌕ Search

Biology subjects

Wijesinghe, A.

Publications and source records attributed to Wijesinghe, A..

2 recordsLinked to original sources

Data-Efficient Exploration of Enzyme Function Using Family-Specific Machine Learning

Enzymes are essential biocatalysts across diverse industries, driving demand for high-performing variants. Foundation models are attractive for guiding enzyme discovery, but often lack the resolution to model subtle variations driving function within homologous families. Navigating these rugged functional landscapes to identify elite variants remains challenging and experimentally costly, even when guided by such models. Here we show that coupling dense, family-specific experimental screening with targeted, sequence-based deep learning provides a data-efficient discovery strategy. We experimentally screened 1,513 natural homologues from an esterase superfamily (>7,500 assays) and used this functional landscape to train task-specific models that predict activity, thermostability, and substrate specificity from sequence alone. Prospective experimental validation of previously untested sequences demonstrated that these task-specific models significantly outperformed generalist pre-trained and physics-based models in enriching for target traits. Residue-level attribution further indicated that the models captured sequence patterns consistent with underlying structural features. Finally, retrospective simulations showed that iterative retraining compresses the search space, discovering 60% of top-tier hits using nearly half the samples required by pre-trained baseline models. Together, these results highlight that machine learning can provide mechanistic insight, and that integrating targeted data acquisition with iterative machine learning provides a more data-efficient discovery strategy than relying on generic model scale.

bioengineering↗

Conjugates for use in peptide therapeutics: a systematic review and meta-analysis

While peptides can be excellent therapeutics for several conditions, their limited in vivo half-lives have been a major bottleneck in the development of therapeutic peptides. Conjugating the peptide to an inert chemical moiety is a strategy that has repeatedly proven to be successful in extending the half-life of some therapeutics. This systematic review and meta-analysis was conducted to examine the available literature and assess it in an unbiased manner to determine which conjugates, both biological and synthetic, provide the greatest increase in therapeutic peptide half-life. Systematic searches run on PubMed, Scopus and SciFinder databases resulted in 845 studies pertaining to the topic, 16 of these were included in this review after assessment against pre-specified inclusion criteria registered on PROSPERO (#CRD42020222579). The most common reasons for exclusion were non-IV administration and large peptide size. Of the 16 studies that were included, a diverse suite of conjugates that increased half-life from 0.1 h to 33.57 h was identified. Amongst these peptides, the largest increase in half-life was seen when conjugated with glycosaminoglycans. A meta-analysis of studies that contained fatty acid conjugates indicated that acylation contributed to a statistically significant extension of half-life. Additionally, another meta-analysis followed by a sensitivity analysis suggested that conjugation with specifically engineered recombinant peptides might contribute to a more efficient extension of peptide half-life as compared to PEGylation. Moreover, we confirmed that while polyethylene glycol is a good synthetic conjugate, its chain length likely has an impact on its effectiveness in extending half-life. Furthermore, we found that most animal studies do not include as much detail when reporting findings as compared to human studies. Inclusion of additional experimental detail on aspects such as independent assessment and randomization may be an easily accomplished strategy to drive more conjugated peptides towards clinical studies.

pharmacology and toxicology↗